DRUG · Unmapped registry intervention
Ryzodeg®
Find medicine records ·
Find other trials using this name
Clinical trial
China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)
NCT05221580
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedChina Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Ryzodeg®DRUG
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
BeijingBeijing Municipality, China2ShanghaiShanghai Municipality, China2NanjingJiangsu, China2TianjinTianjin Municipality, China2HangzhouZhejiang, China1ChangshaHunan, China1WuhanHubei, China1ZhengzhouHenan, China1ShenyangLiaoning, China1ChongqingChongqing Municipality, China1HefeiAnhui, China1HarbinHeilongjiang, China1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05221580 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.